01
Low NADAC$1.73
→
Avg plan cost$3.07
Part D spend $12.5M
2× spread, current vs floor
Drug class profile · refreshed daily from federal data
Ergot Derivative
3 molecules in this class, $23.1M combined CY2024 Part D spend across 195K claims. Class-level guide below for benefits decision-makers: where the money lives, where the savings live.
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annualOrange Book: weeklyShortages: daily
Class summary at a glance.
Every drug in the Ergot Derivative class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.
- Molecules in class
- 3tracked in Part D
- CY24 Part D spend
- $23.1Mcombined across class
- Total Rx claims
- 195K54K unique beneficiaries
- Generic mfrs (active)
- 17across all molecules
Every drug in this class, ranked by Part D spend.
02
Low NADAC$1.45
→
Avg plan cost$1.45
Part D spend $10.1M
1× spread, current vs floor
03
Low NADAC$5.01
→
Avg plan cost$5.01
Part D spend $503249
1× spread, current vs floor